A prospective cohort-based artificial intelligence evaluation system for the protective efficacy and immune response of SARS-CoV-2 inactivated vaccines
-
Published:2024-06
Issue:
Volume:134
Page:112141
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Zhang Jin,
Meng Yuan,
Yang Mei,
Hao Wudi,
Liu Jianhua,
Wu Lina,
Yu Xiaojun,
Zhang Yue,
Lin Baoxu,
Xie Chonghong,
Ge Lili,
Zhijie Zhang ,
Tong Weiwei,
Chang Qing,
Liu Yong,
Zhang Yixiao,
Qin XiaosongORCID
Reference53 articles.
1. Long covid-mechanisms, risk factors, and management;Crook;Bmj,2021
2. Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic;Vilches;JAMA Netw Open,2022
3. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI;Sureshchandra;Insight,2021
4. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants;Accorsi;Jama,2022
5. Painter, M.M., et al., Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies. bioRxiv, 2023.